OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Allergy Asthma & Immunology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency	153
Disparity between mold immunotherapy dosing and practice parameter recommendations in a large healthcare setting	152
LATE-ONSET COMBINED IMMUNE DEFICIENCY IN A PATIENT WITH ADENOSINE DEAMINASE GENE MUTATION	142
RECURRENT LUNG INFECTIONS IN A HETEROZYGOUS CARRIER OF NOVEL NSMCE3 MUTATION.	90
A PATIENT WITH KABUKI SYNDROME AND HYPOGAMMAGLOBULINEMIA DEVELOPS BURKITT LYMPHOMA	84
A UNIQUE CLINICAL PRESENTATION OF COMMON VARIABLE IMMUNODEFICIENCY: MALAKOPLAKIA OF RECTUM.	83
RARE MUTATION IN AIRE GENE IDENTIFIED IN PATIENT WITH VERY EARLY ONSET IBD	76
POST THYMECTOMY: AN EXAMPLE OF IMMUNE DYSREGULATION?	76
A NOVEL PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT VARIANT IDENTIFIED IN T-B-NK+ SEVERE COMBINED IMMUNODEFICIENCY	66
OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA?	62
APPROACHING THE STIFF UPPER LIP: A CASE OF PSEUDOANGIOEDEMA DIAGNOSED AS OROFACIAL GRANULOMATOSIS	54
Information for Readers	51
P061 BENRALIZUMAB IS EFFECTIVE IN REDUCING ASTHMA EXACERBATIONS: RESULTS FROM THE ZEPHYR 2 STUDY	50
P070 EFFICACY OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA STRATIFIED BY BLOOD EOSINOPHIL COUNT	48
P093 IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) 20% SOLUTION ADMINISTRATION IN PRIMARY IMMUNODEFICIENCY DISEASES: A RETROSPECTIVE CHART REVIEW	47
P196 PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS	47
M007 DRESS REACTION TO ANAKINRA IN A PATIENT WITH SEVERE SYSTEMIC JUVENILE ARTHRITIS (SJIA)	46
A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES	45
A032 LATINOS EXPERIENCE LONGER DURATION OF UNCONTROLLED ASTHMA AFTER COVID INFECTION	44
SEVERE INFLAMMATORY RESPONSE SYNDROME AFTER TMP-SMX IN A HEALTHY PATIENT	41
A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection	40
Update in primary immune deficiencies for the practicing allergist/clinical immunologist	39
Asthma, in quest of optimizing care	39
AMELIORATION OF SEVERE EXTRAGENITAL WARTS USING HPV VACCINATION: CASE REPORT AND SURVEY OF THE LITERATURE	38
CHARACTERISTICS OF PEDIATRIC PATIENTS WITH IGE-MEDIATED ALLERGY TO GREEN PEA	36

NOVEL HETEROZYGOUS SINGLE NUCLEOTIDE POLYMORPHISM IN STAT-3 GENE IN PATIENT WITH SUSPECTED HYPER IGE SYNDROME	36
EFFICACY OF PINE NUT-SPECIFIC IGE TESTING PRIOR TO ORAL FOOD CHALLENGE	36
PREVALENCE AND CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS IN 2019	36
M113 BLEPHAROCHALASIS: A HEREDITARY ANGIOEDEMA-MASQUERADER. RECURRENT ANGIOEDEMA IN A 12 YEAR-OLD AFRICAN AMERICAN MALE	34
TYPE II AND III KOUNIS SYNDROME AFTER PEANUT ANAPHYLAXIS	34
M174 HAEMOPHILUS INFLUENZAE TYPE B MENINGITIS – A CASE OF VACCINE FAILURE	34
LIABILITY: A MISUNDERSTOOD BARRIER TO STOCK ALBUTEROL IMPLEMENTATION IN ILLINOIS SCHOOLS	32
IMPACT OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING	32
EPINEPHRINE VIA NEEDLE-FREE DEVICE WOULD BE ADMINISTERED FASTER AFTER SYMPTOMS: RESULTS OF A PATIENT/CAREGIVER SURVEY	32
ENVIRONMENTAL FACTORS INFLUENCING SYMPTOMS AND USE OF RELIEF MEDICATIONS IN SUBJECTS WITH SEASONAL ALLERGIC RHINOCONJUNCTIVITIS	32